Minder System
Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring. De Novo DEN240062, from Epi-Minder Pty, Ltd. (Melbourne, AU). Product code SEM, class 2.
As of Nov 21, 2026, DEN240062 is an FDA De Novo held by Epi-Minder Pty, Ltd., granted on Apr 17, 2025 after 181 days, with no recalls tied to it in FDA's recall database.
- Review time: 181 days
- Recalls: 0
- Cited as a predicate by: 2 devices
“The Minder System is an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. It is a prescription device indicated to acquire, transmit, and store EEGs continuously from patients between 18-75 years of age with drug-resistant epilepsy who are intolerant or not indicated for more conservative monitoring tools.
- Design
- Prospective, open-label, case-controlled comparator study at 6 OUS sites in Australia
- Enrolled
- 31
- Where
- 6 sites, Australia
- Primary endpoint
- Primary safety objective: adverse events (AEs) and serious adverse events (SAEs) from enrollment through study completion
- Result
- 23 of 26 implanted subjects had an AE (128 AEs total); 8 subjects had an SAE (17 SAEs total). No pass/fail threshold stated.
- Minder® SystemK262318 · Epi-Minder Pty, Ltd. · Oct 29, 2026
- UNEEG EpiSight SystemK253607 · Uneeg Medical A/S · Jun 11, 2026
- Minder® SystemK262318 · Epi-Minder Pty, Ltd. · Oct 29, 2026
- UNEEG EpiSight SystemK253607 · Uneeg Medical A/S · Jun 11, 2026
- Type
- Direct
- Received
- Oct 18, 2024
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1360
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files